semaglutide diabetes trial Positive results in testing #GLP-1 targeting #diabetes/#weight-loss medicine (Ozempic, Wegovy) in treatment-seeking patents with #alcohol use disorder (AUD) who were also obese. Alcohol consumed dropped over 70% after 26 weeks Novo Nordisk's semaglutide shows promise

GLP-1 operates through multiple mechanisms, including reducing hunger, increasing a sense of fullness after meals, boosting energy expenditure, and improving insulin sensitivity

Importantly, these methods are not mutually exclusive manufacturers often choose based on the specific need, sometimes even integrating multiple strategies (for instance, creating a nanoemulsion of fish oil then spray-drying it into a polymer-coated powder)

Protein content was determined using Pierce BCA Protein Assay kit (Thermo Fisher Scientific)

CK-MB, creatine kinase isoenzyme-MB

But yet, pharma is the most hated industry in America

Set a reminder to initiate reauthorization before your current approval expires to avoid gaps in coverage